Anifrolumab (Saphnelo) in PEI

April 23, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in PEI effective April 23, 2024.

For more information, please visit the PEI Pharmacare Program website.

Lupus Blog Articles:

The Lupus Canada Annual General Meeting 2026

Read

Disability Benefits in Canada | Pathway to Benefits

Read

Lupus Canada Impact Report 2025 | Advocacy, Awareness & Research Outcomes

Read